Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection

Fig. 5

IP-10 modulation in a second cohort of COVID-19 patients. IP-10 production was measured by ELISA in plasma collected after stimulating whole-blood with Spike peptides. A, B The horizontal lines represent the median of IP-10 production; statistical analysis was performed using the Mann–Whitney test, and p value was considered significant when  ≤  0.05. C, D The graphs represent the AUCs obtained by the ROC analysis comparing the NO-COVID-19 subjects with three cohorts of COVID-19 patients. A, C Hospitalized COVID-19 patients enrolled 1–14 days after symptoms onset. B, D Not-hospitalized COVID-19 patients enrolled 35–100 days after symptoms onset. IP interferon-γ inducible protein; CI confidence interval; AUC area under the curve

Back to article page